MindWalk Holdings Corp.

HYFT Healthcare Biotechnology

MindWalk Holdings Corp.’s revenue for fiscal 2026 (year ended April 2026) was $11.3 million, down 35.9% from fiscal 2025. In the quarter to July 2026, revenue grew 19.4%, EPS fell 80.0%, free cash flow grew 9.79% and total debt fell 10.8%, each against the same quarter a year earlier.

1.31 0.09 −6.43%
Market cap
$66.0M
P/E
0.0×
Fwd P/E
−9.0×
Dividend yield
—
F-score
6/9
Altman Z
−5.59
Beneish M
−3.70
Dividend safety
n/a

MindWalk Holdings Corp. (HYFT) P/E ratio

Alert me on P/E ratio

MindWalk Holdings Corp. has no meaningful P/E ratio: its trailing twelve-month earnings is negative. Over the past ten years it has ranged from 0.0× (October 2026) to 0.0× (October 2026) — the current reading is the highest in ten years.

P/E ratio, daily

Embed this chart

Annual newest first

Period P/E ratio Change
FY2026 0.0× —
FY2025 0.0× —
FY2024 0.0× —
FY2023 0.0× —
FY2022 0.0× —
FY2021 0.0× —
FY2020 0.0× —
FY2019 0.0× —
FY2018 0.0× —
FY2017 0.0× —

Quarterly newest first

Period P/E ratio Change
Jul 2026 0.0× —
Apr 2026 0.0× —
Jan 2026 0.0× —
Oct 2025 0.0× —
23 more quarters

Against its own ten years

Low 0.0× High 0.0×
Ten-year median 0.0×
Current reading's percentile 100

P/E ratio against peers

What P/E ratio is

Price to Earnings Ratio shows how much investors pay for each dollar of a company’s annual profit per share.

Stock Price ÷ EPS (Basic) (TTM)

The full definition of P/E ratio →

More on HYFT